Brokerages Set $56.30 Target Price for Encompass Health Corp (EHC)

Encompass Health Corp (NYSE:EHC) has received an average broker rating score of 1.90 (Buy) from the ten brokers that cover the company, Zacks Investment Research reports. Four equities research analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and five have assigned a strong buy recommendation to the company. Encompass Health’s rating score has improved by 0.5% from three months ago as a result of a number of analysts’ upgrades and downgrades.

Brokerages have set a twelve-month consensus price objective of $56.30 for the company and are expecting that the company will post $0.81 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Encompass Health an industry rank of 75 out of 265 based on the ratings given to related companies.

A number of equities research analysts have recently weighed in on EHC shares. Bank of America raised Encompass Health from an “underperform” rating to a “neutral” rating in a report on Thursday, January 4th. Craig Hallum reissued a “buy” rating and set a $60.00 target price (up previously from $54.00) on shares of Encompass Health in a report on Tuesday, January 9th. ValuEngine raised Encompass Health from a “hold” rating to a “buy” rating in a report on Monday, February 5th. Credit Suisse Group reissued an “outperform” rating on shares of Encompass Health in a report on Tuesday, February 27th. Finally, Piper Jaffray Companies reissued a “hold” rating on shares of Encompass Health in a report on Thursday, March 1st.

Shares of Encompass Health (NYSE:EHC) opened at $58.57 on Tuesday. Encompass Health has a twelve month low of $40.86 and a twelve month high of $59.29. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.79. The firm has a market capitalization of $5,728.38, a price-to-earnings ratio of 21.85, a PEG ratio of 1.39 and a beta of 0.48.

Encompass Health (NYSE:EHC) last posted its earnings results on Monday, February 26th. The company reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.04. Encompass Health had a return on equity of 20.59% and a net margin of 6.45%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1 billion. research analysts forecast that Encompass Health will post 3.36 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Monday, April 2nd will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date of this dividend is Thursday, March 29th. Encompass Health’s dividend payout ratio is currently 37.31%.

ILLEGAL ACTIVITY WARNING: “Brokerages Set $56.30 Target Price for Encompass Health Corp (EHC)” was first published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with's FREE daily email newsletter.

Leave a Reply